Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management
- PMID: 20485578
- PMCID: PMC2868304
Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management
Abstract
Objective: To summarize current views on the pathophysiology, risk factors, prevention, clinical features, and management of Ovarian Hyperstimulation Syndrome (OHSS).
Design: Literature review
Results: OHSS is a condition characterized by increased capillary permeability, and experimental evidence has identified a provocative link to pathologic vasoactive cytokine actions. Although the ultimate physiologic mechanism of OHSS is not yet known, there are well-known risk factors that must be considered during the administration of medications to treat infertility. Clinical features are consequences of third-spaced intravascular fluid, and OHSS may become life-threatening secondary to thromboembolism or compromised pulmonary or cardiovascular function. Cornerstones of prevention have historically included cycle cancellation, coasting, decreased dosing of human chorionic gonadotropin (hCG) trigger, use of an agonist trigger, and cryopreservation of all embryos. Newer methods of prevention include the administration of a dopamine agonist medication. Management options for OHSS include outpatient transvaginal paracentesis, outpatient transabdominal paracentesis, and inpatient hospitalization with or without paracentesis.
Conclusions: OHSS continues to be a serious complication of assisted reproductive therapy (ART), with no universally agreed upon best method of prevention. Coasting and cryopreservation of all embryos are the most commonly used approaches in the literature, but cycle cancellation is the only method that can completely prevent the development of OHSS. Dopamine agonists are currently being investigated to both prevent and improve the clinical course in OHSS. Recent publications suggest that outpatient paracentesis both prevents the need for inpatient hospitalization and is a cost-effective strategy.
Keywords: ascites; coasting; embryo cryopreservation; ovarian hyperstimulation syndrome; paracentesis.
References
-
- Klemetti R, Sevon T, Gissler M, Hemminki E. Complications of IVF and Ovulation Induction. Hum Reprod. 2005;20(12):3293–3300. - PubMed
-
- Derkx FH, Alberda AT, Zeilmaker GH, Shalekamp MA. High concentrations of immunoreactive renin, prorenin, and enzymatically-active renin in human ovarian follicular fluid. Br J Obstet Gynaecol. 1987;94(1):4–9. - PubMed
-
- Lightman A, Tarlatzis BC, Rzasa PJ, Culler MD, Caride VJ, Negro-Vilar AF, Lennard D, DeCherney AH, Naftolin F. The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluid. Am J Obstet Gynecol. 1987;156(4):808–816. - PubMed
-
- De Leener A, Montanelli L, Van Durme J, Chae H, Smits G, Vassart G, Costagliola S. Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab. 2006;91(2):555–562. - PubMed
LinkOut - more resources
Full Text Sources